Suchergebnisse - "Vellenga, Edo"

PubPharm (477)

1

Clonal hematopoiesis in patients with stem cell mobilization failure : a nested case-control study

enthalten in: Blood advances | 2023

von Hazenberg, C. | de Graaf, A. | Mulder, R. | +10

2

Presence of mutant p53 increases stem cell frequency and is associated with reduced binding to classic TP53 binding sites in cell lines and primary AMLs

enthalten in: Experimental hematology | 2022

von Gerritsen, M. | Hilgendorf, S. | Yi, G. | +4

3

USP7 as part of non-canonical PRC1.1 is a druggable target in leukemia

enthalten in: bioRxiv.org | 2022

von Maat, H. | Jaques, J. | Rodríguez López, A. | +9

4

The IL1-IL1RAP axis plays an important role in the inflammatory leukemic niche that favors acute myeloid leukemia proliferation over normal hematopoiesis

enthalten in: Haematologica | 2021

von De Boer, B. | Sheveleva, S. | Apelt, K. | +4

5

Peripheral blood cytopenias in the aging general population and risk of incident hematological disease and mortality

enthalten in: Blood advances | 2021

von van Zeventer, I. | de Graaf, A. | van der Klauw, M. | +7

6

Low relapse risk in poor risk AML after conditioning with 10-day decitabine, fludarabine and 2 Gray TBI prior to allogeneic hematopoietic cell transplantation

enthalten in: Bone marrow transplantation | 2021

von Cruijsen, M. | Hilberink, J. | van der Velden, W. | +10

7

Daratumumab in transfusion-dependent patients with low or intermediate-1 risk myelodysplastic syndromes

enthalten in: American journal of hematology | 2021

von Garcia-Manero, G. | Diez-Campelo, M. | Vellenga, E. | +14

8

Addition of lenalidomide to intensive treatment in younger and middle-aged adults with newly diagnosed AML : the HOVON-SAKK-132 trial

enthalten in: Blood advances | 2021

von Löwenberg, B. | Pabst, T. | Maertens, J. | +45

9

Inferior Outcome of Addition of the Aminopeptidase Inhibitor Tosedostat to Standard Intensive Treatment for Elderly Patients with AML and High Risk MDS

enthalten in: Cancers | 2021

von Janssen, J. | Löwenberg, B. | Manz, M. | +43

10

Imetelstat Achieves Meaningful and Durable Transfusion Independence in High Transfusion-Burden Patients With Lower-Risk Myelodysplastic Syndromes in a Phase II Study

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2021

von Steensma, D. | Fenaux, P. | Van Eygen, K. | +20

CommentIn: J Clin Oncol. 2021 Jan 1;39(1):4-6. - PMID 33275487

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[48]